LEVIN MARK J 4
4 · Fulcrum Therapeutics, Inc. · Filed Jun 15, 2020
Insider Transaction Report
Form 4
LEVIN MARK J
Director10% Owner
Transactions
- Award
Stock Option (right to buy)
2020-06-11+9,285→ 9,285 totalExercise: $17.63Exp: 2030-06-10→ Common Stock (9,285 underlying)
Footnotes (1)
- [F1]This option was granted on June 11, 2020 and is scheduled to vest with respect to all shares on the first anniversary of the grant date or, if earlier, immediately prior to the first annual meeting of stockholders occurring after the grant date, subject to continued service.